首页 > 最新文献

Caspian Journal of Internal Medicine最新文献

英文 中文
Components of geriatric assessment and degree of sarcopenia on maintenance hemodialysis patients. 维持性血液透析患者的老年评估成分及骨骼肌减少程度。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.542
Ihdinal Mukti, Novira Widajanti, Hadiq Firdausi, Djoko Santoso

Background: Sarcopenia is a serious public health problem because of its impact on human health and health care system. The prevalence of sarcopenia in elderly undergoing maintenance hemodialysis is increasing, with various components underlying the geriatric assessment.

Methods: This research used a cross-sectional study approach involving 40 samples taken by total sampling according to inclusion and exclusion criteria. The study population was the entire population aged ≥60 years, male dan female, who routinely undergo hemodialysis at the HD installation at Dr. Soetomo Hospital Surabaya. Data analysis was performed using SPSS Version 25.0.

Results: The research subjects were dominated by 62.5% male elderly with a median age of 64 years (60-93 years). The median duration of hemodialysis was 4 years (0.5-21). The proportion of sarcopenia was 82.5%. From the results of bivariate analysis, it was found that nutritional status as measured by MNA was the only component of CGA associated with sarcopenia p=0,002 (OR 25; IK 95% 3,302-189,259).

Conclusion: Nutritional status is an independent predictor of the incidence of sarcopenia to severe sarcopenia in geriatric patients with chronic kidney disease undergoing maintenance hemodialysis.

背景:骨骼肌减少症是一个严重的公共卫生问题,影响着人类健康和卫生保健系统。在接受维持性血液透析的老年人中,肌肉减少症的患病率正在增加,各种成分构成了老年评估的基础。方法:本研究采用横断面研究方法,按纳入标准和排除标准,采用总抽样法抽取40份样本。研究人群为年龄≥60岁的全部人群,男性和女性,在泗水Soetomo医生医院的HD装置常规接受血液透析。数据分析采用SPSS 25.0版本。结果:研究对象以男性老年人为主,占62.5%,中位年龄64岁(60 ~ 93岁)。血液透析的中位持续时间为4年(0.5-21年)。肌肉减少症占82.5%。从双变量分析的结果中,发现MNA测量的营养状况是CGA与肌肉减少症相关的唯一组成部分p= 0.002 (OR 25;Ik 95% 3,302-189,259)。结论:营养状况是进行维持性血液透析的老年慢性肾病患者骨骼肌减少到严重骨骼肌减少发生率的独立预测因子。
{"title":"Components of geriatric assessment and degree of sarcopenia on maintenance hemodialysis patients.","authors":"Ihdinal Mukti, Novira Widajanti, Hadiq Firdausi, Djoko Santoso","doi":"10.22088/cjim.16.3.542","DOIUrl":"10.22088/cjim.16.3.542","url":null,"abstract":"<p><strong>Background: </strong>Sarcopenia is a serious public health problem because of its impact on human health and health care system. The prevalence of sarcopenia in elderly undergoing maintenance hemodialysis is increasing, with various components underlying the geriatric assessment.</p><p><strong>Methods: </strong>This research used a cross-sectional study approach involving 40 samples taken by total sampling according to inclusion and exclusion criteria. The study population was the entire population aged ≥60 years, male dan female, who routinely undergo hemodialysis at the HD installation at Dr. Soetomo Hospital Surabaya. Data analysis was performed using SPSS Version 25.0.</p><p><strong>Results: </strong>The research subjects were dominated by 62.5% male elderly with a median age of 64 years (60-93 years). The median duration of hemodialysis was 4 years (0.5-21). The proportion of sarcopenia was 82.5%. From the results of bivariate analysis, it was found that nutritional status as measured by MNA was the only component of CGA associated with sarcopenia p=0,002 (OR 25; IK 95% 3,302-189,259).</p><p><strong>Conclusion: </strong>Nutritional status is an independent predictor of the incidence of sarcopenia to severe sarcopenia in geriatric patients with chronic kidney disease undergoing maintenance hemodialysis.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"542-552"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal sarcoidosis mimicking malignancy: A confusing scenario. 胃肠道结节病模拟恶性肿瘤:一个令人困惑的场景。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.584
Dilara Bulut Gökten, Rıdvan Mercan
{"title":"Gastrointestinal sarcoidosis mimicking malignancy: A confusing scenario.","authors":"Dilara Bulut Gökten, Rıdvan Mercan","doi":"10.22088/cjim.16.3.584","DOIUrl":"10.22088/cjim.16.3.584","url":null,"abstract":"","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"584-587"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of HbA1c levels on coronary SYNTAX score in non-diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A cross-sectional study. 非糖尿病st段抬高型心肌梗死患者行原发性血管成形术时HbA1c水平对冠状动脉SYNTAX评分的影响:一项横断面研究
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.519
Majid Saraei Koushki, Razieh Parizad, Ali Abdollahzadeh, Ahmad Separham

Background: Glycated hemoglobin A1c (HbA1c) level is related to increased cardiovascular diseases (CVDs) and death, even in non-diabetic subjects. Although in ST-elevation myocardial infarction (STEMI) cases, the association between HbA1c and coronary artery disease (CAD) remains unclear.

Methods: This cross-sectional study was conducted on 167 non-diabetic STEMI patients undergoing primary percutaneous coronary intervention (PCI). The SYNTAX score was utilized to evaluate CAD severity. Cases were categorized into three groups based on the HbA1c levels: <5%, 5.1-5.9%, and 6-6.5%.

Results: SYNTAX scores significantly increased in the cases with 6 to 6.5 HbA1c levels compared to the other group (28.9±9.5 vs 21.2±5.2 vs 13.7±4.5, P=0.000). Additionally, death was more elevated in this group (4% vs 0% vs 0%, P=0.006).

Conclusion: Higher HbA1c levels are strongly associated with coronary atherosclerosis in non-diabetic patients that present with non-diabetic STEMI. Consequently, in non-diabetic STEMI patients, HbA1c may be able to predict the severity of CAD.

背景:糖化血红蛋白(HbA1c)水平与心血管疾病(cvd)和死亡的增加有关,即使在非糖尿病受试者中也是如此。尽管在st段抬高型心肌梗死(STEMI)病例中,HbA1c与冠状动脉疾病(CAD)之间的关系尚不清楚。方法:本横断面研究对167例非糖尿病STEMI患者进行了经皮冠状动脉介入治疗(PCI)。SYNTAX评分用于评估CAD的严重程度。根据HbA1c水平将病例分为三组:结果:与其他组相比,HbA1c水平为6至6.5的患者SYNTAX评分显著升高(28.9±9.5 vs 21.2±5.2 vs 13.7±4.5,P=0.000)。此外,该组的死亡率更高(4% vs 0% vs 0%, P=0.006)。结论:在非糖尿病STEMI患者中,较高的HbA1c水平与冠状动脉粥样硬化密切相关。因此,在非糖尿病STEMI患者中,HbA1c可能能够预测CAD的严重程度。
{"title":"Impact of HbA1c levels on coronary SYNTAX score in non-diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A cross-sectional study.","authors":"Majid Saraei Koushki, Razieh Parizad, Ali Abdollahzadeh, Ahmad Separham","doi":"10.22088/cjim.16.3.519","DOIUrl":"10.22088/cjim.16.3.519","url":null,"abstract":"<p><strong>Background: </strong>Glycated hemoglobin A1c (HbA1c) level is related to increased cardiovascular diseases (CVDs) and death, even in non-diabetic subjects. Although in ST-elevation myocardial infarction (STEMI) cases, the association between HbA1c and coronary artery disease (CAD) remains unclear.</p><p><strong>Methods: </strong>This cross-sectional study was conducted on 167 non-diabetic STEMI patients undergoing primary percutaneous coronary intervention (PCI). The SYNTAX score was utilized to evaluate CAD severity. Cases were categorized into three groups based on the HbA1c levels: <5%, 5.1-5.9%, and 6-6.5%.</p><p><strong>Results: </strong>SYNTAX scores significantly increased in the cases with 6 to 6.5 HbA1c levels compared to the other group (28.9±9.5 vs 21.2±5.2 vs 13.7±4.5, P=0.000). Additionally, death was more elevated in this group (4% vs 0% vs 0%, P=0.006).</p><p><strong>Conclusion: </strong>Higher HbA1c levels are strongly associated with coronary atherosclerosis in non-diabetic patients that present with non-diabetic STEMI. Consequently, in non-diabetic STEMI patients, HbA1c may be able to predict the severity of CAD.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"519-524"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leptin and thyroid hormones in beta-thalassemia major: A cross-sectional study. 乙型地中海贫血的瘦素和甲状腺激素:一项横断面研究。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.536
Noor Mohammad Noori, Alireza Teimouri, Ayoub Basham, Shahrokh Rajaei

Background: Hypothyroidism and leptin deficiency are two common endocrinopathies in β-thalassemia major patients (β-TM). Changes in leptin levels may lead to changes in thyroid hormone levels in thalassemia patients through suppression of the hypothalamus-pituitary-thyroid axis. Hence, we aimed to evaluate their correlation in β-TM patients.

Methods: A cross-sectional study was conducted on transfusion dependent β-thalassemia patients receiving chelation treatment between 2018 and 2019. Tri-iodothyronine (T3), thyroxine (T4), thyroid stimulating hormone (TSH), and leptin were measured for each participant. Data analyzed by SPSS, p< 0.05 was considered as significant.

Results: One hundred and twenty-six β-TM patients aged between 10 and 30 years old participated in the study, including 55 (43.7%) females and 71(56.3%) males. TSH abnormality was prevalent among 13 (23.6%) females and 10(14.1%) males. Leptin level was significantly lower in males (6.65±7.27 VS 2.41±2.79, p<0.01). TSH was correlated with leptin in all (r=0.393, p<0.01), females (r=0.387, p<0.01), males (r=0.387, p<0.01), adolescents (r=0.512, p<0.01), young adults (r=0.287, P=0.01), underweights (r=0.483, p<0.01) and normal weight (r=0.301, P=0.03) thalassemia patients. T4 was correlated with leptin in all (r=0.201, p=0.02), females (r=0.281, P=0.03), males (r=0.281, P=0.03), and adolescents (r=0.280, P=0.03) β-TM patients. T3 did not correlate with leptin in all groups of the patients.

Conclusion: In summary, leptin levels were significantly lower in males, and TSH abnormality was common in both genders. Therefore, screening for endocrine issues may benefit these people. Furthermore, leptin exhibited a correlation with TSH and T4. This may support the role of leptin on thyroid function in β-TM patients.

背景:甲状腺功能减退和瘦素缺乏是β-地中海贫血主要患者(β-TM)常见的两种内分泌疾病。瘦素水平的变化可能通过抑制下丘脑-垂体-甲状腺轴导致地中海贫血患者甲状腺激素水平的变化。因此,我们的目的是评估它们在β-TM患者中的相关性。方法:对2018 - 2019年接受螯合治疗的输血依赖性β-地中海贫血患者进行横断面研究。测量每位参与者的三碘甲状腺原氨酸(T3)、甲状腺素(T4)、促甲状腺激素(TSH)和瘦素。结果:共纳入10 ~ 30岁β-TM患者126例,其中女性55例(43.7%),男性71例(56.3%)。TSH异常患者女性13例(23.6%),男性10例(14.1%)。男性瘦素水平明显低于男性(6.65±7.27 VS 2.41±2.79)。结论:综上所述,男性瘦素水平明显低于男性,且TSH异常在两性中都很常见。因此,内分泌问题的筛查可能对这些人有益。此外,瘦素与TSH和T4有相关性。这可能支持瘦素对β-TM患者甲状腺功能的作用。
{"title":"Leptin and thyroid hormones in beta-thalassemia major: A cross-sectional study.","authors":"Noor Mohammad Noori, Alireza Teimouri, Ayoub Basham, Shahrokh Rajaei","doi":"10.22088/cjim.16.3.536","DOIUrl":"10.22088/cjim.16.3.536","url":null,"abstract":"<p><strong>Background: </strong>Hypothyroidism and leptin deficiency are two common endocrinopathies in β-thalassemia major patients (β-TM). Changes in leptin levels may lead to changes in thyroid hormone levels in thalassemia patients through suppression of the hypothalamus-pituitary-thyroid axis. Hence, we aimed to evaluate their correlation in β-TM patients.</p><p><strong>Methods: </strong>A cross-sectional study was conducted on transfusion dependent β-thalassemia patients receiving chelation treatment between 2018 and 2019. Tri-iodothyronine (T3), thyroxine (T4), thyroid stimulating hormone (TSH), and leptin were measured for each participant. Data analyzed by SPSS, p< 0.05 was considered as significant.</p><p><strong>Results: </strong>One hundred and twenty-six β-TM patients aged between 10 and 30 years old participated in the study, including 55 (43.7%) females and 71(56.3%) males. TSH abnormality was prevalent among 13 (23.6%) females and 10(14.1%) males. Leptin level was significantly lower in males (6.65±7.27 VS 2.41±2.79, p<0.01). TSH was correlated with leptin in all (r=0.393, p<0.01), females (r=0.387, p<0.01), males (r=0.387, p<0.01), adolescents (r=0.512, p<0.01), young adults (r=0.287, P=0.01), underweights (r=0.483, p<0.01) and normal weight (r=0.301, P=0.03) thalassemia patients. T4 was correlated with leptin in all (r=0.201, p=0.02), females (r=0.281, P=0.03), males (r=0.281, P=0.03), and adolescents (r=0.280, P=0.03) β-TM patients. T3 did not correlate with leptin in all groups of the patients.</p><p><strong>Conclusion: </strong>In summary, leptin levels were significantly lower in males, and TSH abnormality was common in both genders. Therefore, screening for endocrine issues may benefit these people. Furthermore, leptin exhibited a correlation with TSH and T4. This may support the role of leptin on thyroid function in β-TM patients.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"536-541"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow. 基于骨髓组织病理学评价的多发性骨髓瘤患者预后。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.562
Niloofar Arefi Sigaroudi, Mohsen Vakili Sadeghi, Housein Ghorbani, Davood Jahansouz, Hoda Shirafkan, Mohammad Ranaee

Background: Multiple myeloma is still one of deadliest malignancies known. Although many attempts to prognosticate the disease have been done like the International Staging System (ISS), most of the proposed prognostic tools are based merely on laboratory tests and hence prone to analytical errors in large and high-volume centers. This study aims to evaluate the prognostic effectiveness of histopathologic components of bone marrow and compare it to the results of laboratory-based prognostic tools.

Methods: This cross-sectional study, bone marrow specimens of 93 multiple myeloma patients underwent aspiration and biopsy evaluated. The primary outcome was overall survival (OS) based on plasma cell percentage. The secondary outcomes were also OS based on angiogenesis using IHC marker CD34, nuclear atypia level, BM involvement pattern and the presence of fibrosis in bone marrow specimens. All biopsy specimens assessed using light microscopy on Hematoxylin and Eosin and IHC staining. Giemsa staining assessed for aspirate specimens.

Results: Of 93 patients, 63.4% were dead. Median survival was 34.0 months (95% CI [24.6; 43.3]) and the average age at diagnosis was 65 years (highest 84 and lowest 40). Patients with bone marrow plasma cell count of over 70%, had a hazard ratio (HR) of death of 4.7 times more than those with plasma cell count between 10-25%. Similarly, diffuse infiltration pattern (HR 4.67) and blastic morphology (HR 4.17) associated with a significant worse prognosis (p=0.03).

Conclusion: Comparing to laboratory-based ISS, wider HR of death spectrum in this study proposes a potential more precise, robust and easy-to-use prognostication tool.

背景:多发性骨髓瘤仍然是已知的最致命的恶性肿瘤之一。虽然许多预测疾病的尝试已经完成,如国际分期系统(ISS),但大多数建议的预测工具仅仅基于实验室测试,因此在大型和高容量的中心容易出现分析错误。本研究旨在评估骨髓组织病理学成分的预后效果,并将其与基于实验室的预后工具的结果进行比较。方法:对93例多发性骨髓瘤患者的骨髓标本进行抽吸和活检。主要终点是基于浆细胞百分比的总生存期(OS)。次要结果还包括基于IHC标志物CD34的血管生成、核异型性水平、骨髓浸润模式和骨髓标本中纤维化的存在的OS。所有活检标本采用苏木精和伊红光镜及免疫组化染色进行评估。吸入标本的吉姆萨染色评估。结果:93例患者死亡63.4%。中位生存期为34.0个月(95% CI [24.6;[43.3]),平均诊断年龄65岁(最高84岁,最低40岁)。骨髓浆细胞计数大于70%的患者的死亡危险比(HR)是浆细胞计数在10 ~ 25%之间的患者的4.7倍。同样,弥漫性浸润模式(HR 4.67)和母细胞形态(HR 4.17)与预后明显较差相关(p=0.03)。结论:与基于实验室的ISS相比,本研究中更广泛的死亡谱HR提供了一种潜在的更精确、更稳健、更易于使用的预测工具。
{"title":"Prognosis of multiple myeloma patients based on histopathological evaluation of bone marrow.","authors":"Niloofar Arefi Sigaroudi, Mohsen Vakili Sadeghi, Housein Ghorbani, Davood Jahansouz, Hoda Shirafkan, Mohammad Ranaee","doi":"10.22088/cjim.16.3.562","DOIUrl":"10.22088/cjim.16.3.562","url":null,"abstract":"<p><strong>Background: </strong>Multiple myeloma is still one of deadliest malignancies known. Although many attempts to prognosticate the disease have been done like the International Staging System (ISS), most of the proposed prognostic tools are based merely on laboratory tests and hence prone to analytical errors in large and high-volume centers. This study aims to evaluate the prognostic effectiveness of histopathologic components of bone marrow and compare it to the results of laboratory-based prognostic tools.</p><p><strong>Methods: </strong>This cross-sectional study, bone marrow specimens of 93 multiple myeloma patients underwent aspiration and biopsy evaluated. The primary outcome was overall survival (OS) based on plasma cell percentage. The secondary outcomes were also OS based on angiogenesis using IHC marker CD34, nuclear atypia level, BM involvement pattern and the presence of fibrosis in bone marrow specimens. All biopsy specimens assessed using light microscopy on Hematoxylin and Eosin and IHC staining. Giemsa staining assessed for aspirate specimens.</p><p><strong>Results: </strong>Of 93 patients, 63.4% were dead. Median survival was 34.0 months (95% CI [24.6; 43.3]) and the average age at diagnosis was 65 years (highest 84 and lowest 40). Patients with bone marrow plasma cell count of over 70%, had a hazard ratio (HR) of death of 4.7 times more than those with plasma cell count between 10-25%. Similarly, diffuse infiltration pattern (HR 4.67) and blastic morphology (HR 4.17) associated with a significant worse prognosis (p=0.03).</p><p><strong>Conclusion: </strong>Comparing to laboratory-based ISS, wider HR of death spectrum in this study proposes a potential more precise, robust and easy-to-use prognostication tool.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"562-569"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329366/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary alveolar microlithiasis: A case report and brief review of literature. 肺泡微石症1例报告及文献复习。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.570
Reza Mohseni Ahangar, Mohammad Golparvar Azizi, Sara Babazadeh, Seyed Ali Akbar Hosseini Nasab, Ali Tavakoli Pirzaman

Background: Pulmonary alveolar microlithiasis (PAM), a rare autosomal recessive pulmonary disease, is mainly characterized by extensive calcium phosphate microliths deposition in the alveoli. The major mutation, causing the characteristic of this disease, occurs in solute carrier family 34 members 2 (SLC34A2), which is placed on chromosome 4p15.2. SLC34A2 encodes sodium-phosphate cotransporter type IIb, NPT2b, which plays a critical role in the transportation of phosphate ions from pulmonary alveoli into type II pneumocytes.

Case presentation: Herein, we have reported a 50-year-old male presented with recent sore throat, fever, and sweating. Radiological findings revealed bilateral micronodular pattern with diffuse ground glass attenuation in lower regions. Subsequent histologic examination of lung biopsy confirmed intra-alveolar accumulation of calculi and the diagnosis of PAM. In addition, we reviewed the literature narratively to clarify different aspects of PAM.

Conclusion: In this paper, we presented a sporadic case of PAM which was suspected with chest x-ray and confirmed by HRCT and trans-bronchial lung biopsy. We hope that it can help clinicians to be more aware of this condition and make proper diagnosis.

背景:肺泡微石症(PAM)是一种罕见的常染色体隐性肺部疾病,主要表现为肺泡内广泛的磷酸钙微石沉积。导致这种疾病特征的主要突变发生在溶质载体家族34成员2 (SLC34A2)中,位于染色体4p15.2上。SLC34A2编码磷酸钠共转运蛋白IIb、NPT2b,在磷酸离子从肺泡转运到II型肺细胞中起关键作用。病例介绍:在此,我们报告了一名50岁男性,最近出现喉咙痛、发烧和出汗。放射学表现为双侧微结节型,下部弥漫性磨玻璃衰减。随后的肺活检组织学检查证实肺泡内结石积聚和PAM的诊断。此外,我们回顾了文献叙述,以澄清PAM的不同方面。结论:本文报告1例散在性PAM,经胸片怀疑,HRCT及经支气管肺活检证实。我们希望它能帮助临床医生更多地了解这种情况并做出正确的诊断。
{"title":"Pulmonary alveolar microlithiasis: A case report and brief review of literature.","authors":"Reza Mohseni Ahangar, Mohammad Golparvar Azizi, Sara Babazadeh, Seyed Ali Akbar Hosseini Nasab, Ali Tavakoli Pirzaman","doi":"10.22088/cjim.16.3.570","DOIUrl":"10.22088/cjim.16.3.570","url":null,"abstract":"<p><strong>Background: </strong>Pulmonary alveolar microlithiasis (PAM), a rare autosomal recessive pulmonary disease, is mainly characterized by extensive calcium phosphate microliths deposition in the alveoli. The major mutation, causing the characteristic of this disease, occurs in solute carrier family 34 members 2 (SLC34A2), which is placed on chromosome 4p15.2. SLC34A2 encodes sodium-phosphate cotransporter type IIb, NPT2b, which plays a critical role in the transportation of phosphate ions from pulmonary alveoli into type II pneumocytes.</p><p><strong>Case presentation: </strong>Herein, we have reported a 50-year-old male presented with recent sore throat, fever, and sweating. Radiological findings revealed bilateral micronodular pattern with diffuse ground glass attenuation in lower regions. Subsequent histologic examination of lung biopsy confirmed intra-alveolar accumulation of calculi and the diagnosis of PAM. In addition, we reviewed the literature narratively to clarify different aspects of PAM.</p><p><strong>Conclusion: </strong>In this paper, we presented a sporadic case of PAM which was suspected with chest x-ray and confirmed by HRCT and trans-bronchial lung biopsy. We hope that it can help clinicians to be more aware of this condition and make proper diagnosis.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"570-576"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pulmonary function test and carotid intima-media thickness in chronic obstructive pulmonary disease. 慢性阻塞性肺疾病肺功能检查与颈动脉内膜-中膜厚度的关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.487
Shahabaddin Sorouri, Maryam Naseri, Sepideh Hejazi

Background: Studies have shown that carotid intima-media thickness (CIMT) is an indicator of cardiovascular events and mortality and its increase has correlation with severe airflow obstruction in patients with COPD. The aim of this study was to investigate the association between pulmonary function and CIMT in COPD patients.

Methods: This study was performed on two groups of patients with and without COPD (cases & controls) who were referred to pulmonary clinics. Demographic, clinical, and laboratory tests were recorded in questionnaire. Spirometry was performed in cases and FVC, FEV1, and FEV1/FVC were measured. CIMT was determined via ultrasound.

Results: Our results indicated that right carotid IMT was 0.51±0.112 mm and 0.65±0.131 mm in the control and case groups, respectively (p< 0.001). Left CIMT was 0.48±0.089 mm and 0.68±0.113 mm in the control and case groups, respectively (p< 0.001). FEV1 and FEV1/FVC had an inverse and significant correlation with IMT of the carotid (both right and left carotid).

Conclusion: The results indicated an inverse association between carotid IMT and lung function test in COPD patients.

背景:研究表明,颈动脉内膜-中膜厚度(CIMT)是COPD患者心血管事件和死亡率的一个指标,其升高与COPD患者严重气流阻塞有关。本研究的目的是探讨COPD患者肺功能与CIMT之间的关系。方法:本研究对两组转介到肺病诊所的COPD患者(病例和对照组)进行了研究。在问卷中记录人口学、临床和实验室检查结果。患者行肺活量测定,测量FVC、FEV1、FEV1/FVC。超声检测CIMT。结果:对照组和病例组右颈动脉IMT分别为0.51±0.112 mm和0.65±0.131 mm (p< 0.001)。对照组和病例组左CIMT分别为0.48±0.089 mm和0.68±0.113 mm (p< 0.001)。FEV1和FEV1/FVC与颈动脉(右颈和左颈)IMT呈显著负相关。结论:COPD患者颈动脉IMT与肺功能测试呈负相关。
{"title":"Pulmonary function test and carotid intima-media thickness in chronic obstructive pulmonary disease.","authors":"Shahabaddin Sorouri, Maryam Naseri, Sepideh Hejazi","doi":"10.22088/cjim.16.3.487","DOIUrl":"10.22088/cjim.16.3.487","url":null,"abstract":"<p><strong>Background: </strong>Studies have shown that carotid intima-media thickness (CIMT) is an indicator of cardiovascular events and mortality and its increase has correlation with severe airflow obstruction in patients with COPD. The aim of this study was to investigate the association between pulmonary function and CIMT in COPD patients.</p><p><strong>Methods: </strong>This study was performed on two groups of patients with and without COPD (cases & controls) who were referred to pulmonary clinics. Demographic, clinical, and laboratory tests were recorded in questionnaire. Spirometry was performed in cases and FVC, FEV1, and FEV1/FVC were measured. CIMT was determined via ultrasound.</p><p><strong>Results: </strong>Our results indicated that right carotid IMT was 0.51±0.112 mm and 0.65±0.131 mm in the control and case groups, respectively (p< 0.001). Left CIMT was 0.48±0.089 mm and 0.68±0.113 mm in the control and case groups, respectively (p< 0.001). FEV1 and FEV1/FVC had an inverse and significant correlation with IMT of the carotid (both right and left carotid).</p><p><strong>Conclusion: </strong>The results indicated an inverse association between carotid IMT and lung function test in COPD patients.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"487-492"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rituximab versus azathioprine in maintenance therapy of patients with granulomatosis with polyangiitis. 利妥昔单抗与硫唑嘌呤在肉芽肿合并多血管炎患者维持治疗中的比较。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.480
Samira Alesaeidi, Masoud Radnia, Soheil Tavakolpour, Seyed Behnam Jazayeri, Shima Loni

Background: Granulomatosis with polyangiitis (GPA) is a rare disease affecting medium-small vessels, causing granuloma formation and inflammation. This study aimed to assess the efficacy and safety of RTX versus Azathioprine (AZA) for maintenance treatment in GPA patients.

Methods: This retrospective cohort study involved a review of medical records of recently diagnosed GPA patients undergoing maintenance treatment with RTX or AZA. The main variable was the frequency of relapses within an 18-month follow-up period. Additionally, the study compared changes in BVAS.WG score (The Birmingham Vasculitis Activity Score-Wegner specific) and Damage (vasculitis damage index (VDI)), mortality, and treatment complications between the two groups.

Results: Among the 43 patients receiving RTX maintenance treatment, 8 (18.6%) experienced relapses during 24 months follow-up, while 14 (66.6%) out of the 21 patients receiving AZA relapsed (Hazard Ratio = 6.9 and 95% confidence interval = 1.95-19.3, p <001). Notably, the increase in the BVAS-WG score was significantly lower in the RTX group compared to the AZA group (p <001). The cumulative steroid dose was 143±21 mg in the RTX group and 125±25 mg in the AZA group (P = 0.1). Treatment side effects were similar in both groups (p >0.05).

Conclusion: Maintenance treatment with RTX is associated with better treatment response and lower relapse rate compared to AZA. There was no difference in treatment complications between AZA or RTX in maintenance treatment.

背景:肉芽肿病合并多血管炎(GPA)是一种少见的影响中小血管的疾病,可引起肉芽肿形成和炎症。本研究旨在评估RTX与硫唑嘌呤(AZA)在GPA患者维持治疗中的有效性和安全性。方法:本回顾性队列研究回顾了最近确诊的GPA患者接受RTX或AZA维持治疗的医疗记录。主要变量是18个月随访期间的复发频率。此外,该研究还比较了BVAS的变化。两组间WG评分(伯明翰血管炎活动评分- wegner特异性)和损伤(血管炎损伤指数(VDI))、死亡率和治疗并发症的比较。结果:在接受RTX维持治疗的43例患者中,随访24个月复发8例(18.6%),而接受AZA治疗的21例患者中复发14例(66.6%)(风险比= 6.9,95%可信区间= 1.95 ~ 19.3,p 0.05)。结论:与AZA相比,RTX维持治疗具有更好的治疗效果和更低的复发率。在维持治疗中,AZA与RTX治疗并发症无差异。
{"title":"Rituximab versus azathioprine in maintenance therapy of patients with granulomatosis with polyangiitis.","authors":"Samira Alesaeidi, Masoud Radnia, Soheil Tavakolpour, Seyed Behnam Jazayeri, Shima Loni","doi":"10.22088/cjim.16.3.480","DOIUrl":"10.22088/cjim.16.3.480","url":null,"abstract":"<p><strong>Background: </strong>Granulomatosis with polyangiitis (GPA) is a rare disease affecting medium-small vessels, causing granuloma formation and inflammation. This study aimed to assess the efficacy and safety of RTX versus Azathioprine (AZA) for maintenance treatment in GPA patients.</p><p><strong>Methods: </strong>This retrospective cohort study involved a review of medical records of recently diagnosed GPA patients undergoing maintenance treatment with RTX or AZA. The main variable was the frequency of relapses within an 18-month follow-up period. Additionally, the study compared changes in BVAS.WG score (The Birmingham Vasculitis Activity Score-Wegner specific) and Damage (vasculitis damage index (VDI)), mortality, and treatment complications between the two groups.</p><p><strong>Results: </strong>Among the 43 patients receiving RTX maintenance treatment, 8 (18.6%) experienced relapses during 24 months follow-up, while 14 (66.6%) out of the 21 patients receiving AZA relapsed (Hazard Ratio = 6.9 and 95% confidence interval = 1.95-19.3, p <001). Notably, the increase in the BVAS-WG score was significantly lower in the RTX group compared to the AZA group (p <001). The cumulative steroid dose was 143±21 mg in the RTX group and 125±25 mg in the AZA group (P = 0.1). Treatment side effects were similar in both groups (p >0.05).</p><p><strong>Conclusion: </strong>Maintenance treatment with RTX is associated with better treatment response and lower relapse rate compared to AZA. There was no difference in treatment complications between AZA or RTX in maintenance treatment.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"480-486"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329910/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus. 2型糖尿病患者血清鸢尾素水平与肾功能的关系。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.493
Robab Aboutorabi, Golrokh Hariri, Zahra Mazloum Khorasani, Hassan Mehrad-Majd

Background: Irisin, a myokine implicated in metabolic hemostasis, have been investigated in relation to type 2 diabetes mellitus (T2DM), yet findings on its serum levels and association with diabetic complications such as nephropathy remain inconsistent. This study aimed to assess the relationship between serum irisin levels and renal function in T2DM patients.

Methods: A cross-sectional study was conducted involving 140 individuals diagnosed with T2DM. Demographic, anthropometric, and clinical data were recorded. Fasting blood samples were collected to determine serum irisin levels using the ELISA method. Additional biochemical measurements included fasting blood glucose, creatinine, HDL, LDL, triglycerides, HbA1c, and urinary albumin. Correlations between irisin levels and these parameters were analyzed. Patients were divided into two groups based on glomerular filtration rate (GFR) and albumin-to-creatinine ratio (ACR) to assess associations between irisin levels and renal function.

Results: No statistically significant difference in serum irisin levels was observed between patients with reduced renal function (GFR≤60) and those with GFR>60 (10.45±6.54 vs. 13.32±10.59 ng/ml, P=0.08). In stratified analysis by ACR, patients with nephropathy displayed a non-significantly lower irisin level than those without (11.70±8.18 vs. 13.38±11.51, P=0.33). Serum irisin showed no significant correlations with FBS (P=0.05), insulin (P=0.06), LDL (P=0.96), HDL (P=0.61), or BMI (P=0.42).

Conclusion: Lower irisin levels in T2DM patients with reduced renal function or nephropathy may indicate a potential role for irisin in diabetic renal disease progression. Serum irisin could serve as a prognostic biomarker for diabetic nephropathy pending further validation.

背景:鸢尾素是一种与代谢性止血有关的肌肉因子,已被研究与2型糖尿病(T2DM)的关系,但其血清水平及其与糖尿病并发症(如肾病)的关系仍不一致。本研究旨在评估2型糖尿病患者血清鸢尾素水平与肾功能的关系。方法:对140例T2DM患者进行横断面研究。记录了人口统计学、人体测量学和临床数据。采集空腹血样,采用ELISA法测定血清鸢尾素水平。其他生化指标包括空腹血糖、肌酐、HDL、LDL、甘油三酯、HbA1c和尿白蛋白。分析鸢尾素水平与这些参数的相关性。根据肾小球滤过率(GFR)和白蛋白与肌酐比(ACR)将患者分为两组,以评估鸢尾素水平与肾功能之间的关系。结果:GFR≤60组与GFR≤60组血清鸢尾素水平差异无统计学意义(10.45±6.54∶13.32±10.59 ng/ml, P=0.08)。ACR分层分析显示,肾病患者鸢尾素水平低于无肾病患者(11.70±8.18∶13.38±11.51,P=0.33)。血清鸢尾素与FBS (P=0.05)、胰岛素(P=0.06)、LDL (P=0.96)、HDL (P=0.61)、BMI (P=0.42)无显著相关性。结论:伴有肾功能减退或肾病的T2DM患者鸢尾素水平降低可能提示鸢尾素在糖尿病肾病进展中的潜在作用。血清鸢尾素可作为糖尿病肾病的预后生物标志物,有待进一步验证。
{"title":"Relationship between serum irisin levels and renal function in patients with type 2 diabetes mellitus.","authors":"Robab Aboutorabi, Golrokh Hariri, Zahra Mazloum Khorasani, Hassan Mehrad-Majd","doi":"10.22088/cjim.16.3.493","DOIUrl":"10.22088/cjim.16.3.493","url":null,"abstract":"<p><strong>Background: </strong>Irisin, a myokine implicated in metabolic hemostasis, have been investigated in relation to type 2 diabetes mellitus (T2DM), yet findings on its serum levels and association with diabetic complications such as nephropathy remain inconsistent. This study aimed to assess the relationship between serum irisin levels and renal function in T2DM patients.</p><p><strong>Methods: </strong>A cross-sectional study was conducted involving 140 individuals diagnosed with T2DM. Demographic, anthropometric, and clinical data were recorded. Fasting blood samples were collected to determine serum irisin levels using the ELISA method. Additional biochemical measurements included fasting blood glucose, creatinine, HDL, LDL, triglycerides, HbA1c, and urinary albumin. Correlations between irisin levels and these parameters were analyzed. Patients were divided into two groups based on glomerular filtration rate (GFR) and albumin-to-creatinine ratio (ACR) to assess associations between irisin levels and renal function.</p><p><strong>Results: </strong>No statistically significant difference in serum irisin levels was observed between patients with reduced renal function (GFR≤60) and those with GFR>60 (10.45±6.54 vs. 13.32±10.59 ng/ml, P=0.08). In stratified analysis by ACR, patients with nephropathy displayed a non-significantly lower irisin level than those without (11.70±8.18 vs. 13.38±11.51, P=0.33). Serum irisin showed no significant correlations with FBS (P=0.05), insulin (P=0.06), LDL (P=0.96), HDL (P=0.61), or BMI (P=0.42).</p><p><strong>Conclusion: </strong>Lower irisin levels in T2DM patients with reduced renal function or nephropathy may indicate a potential role for irisin in diabetic renal disease progression. Serum irisin could serve as a prognostic biomarker for diabetic nephropathy pending further validation.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"493-499"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyoderma gangrenosum, as the first clinical presentation of systemic lupus erythematous, a case report and comprehensive literature review. 坏疽性脓皮病,作为系统性红斑狼疮的首发临床表现,报告1例并综合文献复习。
IF 1 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-23 eCollection Date: 2025-01-01 DOI: 10.22088/cjim.16.3.577
Shahrzad Rahmani, Azadeh Goodarzi, Amirhossein Akbarzadehpasha, Homa Abri, Amir Mohamad Sadeghian, Elham Behrangi, Azadeh Laali, Nasrin Shayanfar, Shiva Lotfi

Background: Pyoderma gangrenosum (PG) can be related to a range of systemic and hematologic diseases. The relationship between systemic lupus erythematosus (SLE) and PG has rarely been discussed.

Case presentation: In this case study, we report on an SLE patient who presented with PG. The patient is a 53-year-old woman with the chief complaint of developing painful erythematous pustules on her right flank 3 days after hysterectomy surgery. In the span of 3 months, the patient was treated with antibiotics and intra-lesional corticosteroids with no improvement. Meanwhile, she developed symptoms such as polyarthralgia, pleural effusion, hemolytic anemia, and thrombocytopenia, while anti-dsDNA came out positive.

Result: Based on pathology results in combination with clinical and para-clinical findings according to the SLICC criteria for SLE 2012, our patient was diagnosed as an active case of SLE presenting with PG. We also searched for and gathered the latest articles on this issue (from 2017 until 2022) to present the most updated review study on the topic in this article.

Conclusion: Considering the abundance of PG and SLE concomitance reported cases (more than 30), it might be time to pay more attention to SLE as the underlying cause of PG and keep in mind that any unhealing ulcer in patients with connective tissue disorders should be evaluated for PG. Considering the various treatment options for PG, it is essential that the treatment of choice should cover symptoms of both PG and the underlying disease.

背景:坏疽性脓皮病(Pyoderma gangrenosum, PG)可与一系列全身和血液系统疾病相关。系统性红斑狼疮(SLE)与PG之间的关系很少被讨论。病例介绍:在本病例研究中,我们报告了一例以PG为表现的SLE患者。患者是一名53岁的女性,主诉为子宫切除术后3天右侧出现疼痛的红斑脓疱。在3个月的时间里,患者接受了抗生素和病灶内皮质类固醇治疗,没有任何改善。同时出现多关节痛、胸腔积液、溶血性贫血、血小板减少症等症状,抗dsdna阳性。结果:根据SLE 2012的SLICC标准,根据病理结果结合临床和临床旁表现,我们的患者被诊断为以PG为表现的SLE活动性病例。我们还检索并收集了有关该问题的最新文章(从2017年到2022年),以提供本文中关于该主题的最新综述研究。结论:考虑到PG和SLE合并报道病例的丰富程度(超过30例),可能是时候更多地关注SLE作为PG的潜在病因,并记住结缔组织疾病患者的任何未愈合溃疡都应评估PG。考虑到PG的各种治疗方案,选择治疗方案必须涵盖PG和潜在疾病的症状。
{"title":"Pyoderma gangrenosum, as the first clinical presentation of systemic lupus erythematous, a case report and comprehensive literature review.","authors":"Shahrzad Rahmani, Azadeh Goodarzi, Amirhossein Akbarzadehpasha, Homa Abri, Amir Mohamad Sadeghian, Elham Behrangi, Azadeh Laali, Nasrin Shayanfar, Shiva Lotfi","doi":"10.22088/cjim.16.3.577","DOIUrl":"10.22088/cjim.16.3.577","url":null,"abstract":"<p><strong>Background: </strong>Pyoderma gangrenosum (PG) can be related to a range of systemic and hematologic diseases. The relationship between systemic lupus erythematosus (SLE) and PG has rarely been discussed.</p><p><strong>Case presentation: </strong>In this case study, we report on an SLE patient who presented with PG. The patient is a 53-year-old woman with the chief complaint of developing painful erythematous pustules on her right flank 3 days after hysterectomy surgery. In the span of 3 months, the patient was treated with antibiotics and intra-lesional corticosteroids with no improvement. Meanwhile, she developed symptoms such as polyarthralgia, pleural effusion, hemolytic anemia, and thrombocytopenia, while anti-dsDNA came out positive.</p><p><strong>Result: </strong>Based on pathology results in combination with clinical and para-clinical findings according to the SLICC criteria for SLE 2012, our patient was diagnosed as an active case of SLE presenting with PG. We also searched for and gathered the latest articles on this issue (from 2017 until 2022) to present the most updated review study on the topic in this article.</p><p><strong>Conclusion: </strong>Considering the abundance of PG and SLE concomitance reported cases (more than 30), it might be time to pay more attention to SLE as the underlying cause of PG and keep in mind that any unhealing ulcer in patients with connective tissue disorders should be evaluated for PG. Considering the various treatment options for PG, it is essential that the treatment of choice should cover symptoms of both PG and the underlying disease.</p>","PeriodicalId":9646,"journal":{"name":"Caspian Journal of Internal Medicine","volume":"16 3","pages":"577-583"},"PeriodicalIF":1.0,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12329354/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Caspian Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1